Related Experiment Video

Updated: Jul 4, 2025

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

55.2K

Correction: The deficiency of Maged1 attenuates Parkinson's disease progression in mice

Jie Wang1, Sheng-Ye Xu1, Zhi-Yuan Ye1

  • 1Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.

Molecular Brain
|February 9, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.6K
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
08:06

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

31.6K

Related Experiment Videos

Last Updated: Jul 4, 2025

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

55.2K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.6K
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
08:06

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

31.6K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268

Articles linked to this work by shared authors, journal, and citation graph.

Targeting Microglial HDAC5 Suppresses NLRP3 Inflammation via NF-κB Deacetylation to Alleviate Ischemic Brain Injury.

CNS neuroscience & therapeutics·2026

Chronic Intermittent Hypoxia Disrupts Intestinal Homeostasis Through Gut Microbiota Remodeling and Microbiota-Metabolite Interactions.

Biomolecules·2026

Mechanism-Driven Nanoformulations for Cognitive Impairment Induced by Intermittent Hypoxia and Periodontitis.

Advanced materials (Deerfield Beach, Fla.)·2026

Chronic Intermittent Hypoxia Exacerbates High-Fat Diet-Induced MASLD Through Lipid Metabolic Reprogramming, Impaired Antioxidant Defense, and NF-κB/NLRP3 Activation.

Biomolecules·2026

CSNK1D inhibition suppresses head and neck squamous cell carcinoma progression through SHH and PTCH1 pathway.

Cell death & disease·2025

Suppression of 6-pyruvoyl-tetrahydropterin synthase promotes remyelination in multiple sclerosis.

BMC medicine·2025

PPM1H loss alters intrasynaptic alpha-synuclein localization in a LRRK2-dependent manner.

Molecular brain·2026

Ferroptosis as an immunometabolic checkpoint in brain tumours: spatial vulnerabilities and therapeutic opportunities.

Molecular brain·2026

Semaglutide alters behaviour and nucleus accumbens oscillatory activity in healthy mice.

Molecular brain·2026

CAST controls presynaptic sequestration of Rab6 in neurons.

Molecular brain·2026

Temperature-dependent functional inversion of Cav3.2 channels during repetitive activity.

Molecular brain·2026

Zinc-mediated lysosomal activation by 1H10 enhances autophagy and attenuates tau pathology in Alzheimer's disease models.

Molecular brain·2026

Low amplitude pulse seizure therapy (LAP-ST): a form of seizure therapy with potential for reduced cognitive and memory side effects - a narrative review.

Expert review of neurotherapeutics·2026

Bilateral Latent Synergy-Informed Residual sEMG Reconstruction for Incomplete Hand Gesture Recognition in Hemiparetic Patients.

IEEE transactions on bio-medical engineering·2026

Musical Episodic Modulation of Human Functioning: Anticipation Mechanisms, Personal Sense, and Emotional Recall.

Integrative psychological & behavioral science·2026

The effects of delayed auditory feedback depend on both the rhythm and content of the feedback signal.

Frontiers in human neuroscience·2026

The language network does not support music perception across a range of music experience.

bioRxiv : the preprint server for biology·2026

Electrophysiological evidence that musical experience affects spatial auditory perception.

Cerebral cortex (New York, N.Y. : 1991)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us